[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Page 10389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03902]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-958]


Importer of Controlled Substances Application: Noramco Coventry 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Noramco Coventry LLC has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 28, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before March 28, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on September 29, 2021, Noramco Coventry LLC, 498 
Washington Street, Coventry, Rhode Island 02816, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols...................    7370  I
Methylphenidate.........................    1724  II
Oxycodone...............................    9143  II
Hydromorphone...........................    9150  II
Hydrocodone.............................    9193  II
Morphine................................    9300  II
Opium, raw..............................    9600  II
Oxymorphone.............................    9652  II
Poppy Straw Concentrate.................    9670  II
------------------------------------------------------------------------

    The company plans to import Opium, raw (9600), and Poppy Straw 
Concentrate (9670) in order to bulk manufacture-controlled substances 
in Active Pharmaceutical Ingredient (API) form. The company will use 
the imported narcotic raw materials in ancillary activities including 
process development and analytical studies. Noramco does not anticipate 
redistributing the imported narcotic raw materials domestically to 
other registered bulk manufacturers. The company plans to import the 
other listed controlled substances for internal reference standards use 
only. No other activity for these drug codes is authorized for this 
registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-03902 Filed 2-23-22; 8:45 am]
BILLING CODE P